Fate Therapeutics, Inc.

FATE · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$40,622$41,249$44,920$36,056
Short-Term Investments$174,801$181,581$195,505$243,012
Receivables$682$1,395$2,406$3,539
Inventory$0$0$0$0
Other Curr. Assets$5,146$6,172$5,386$9,302
Total Curr. Assets$221,251$230,397$248,217$291,909
Property Plant & Equip (Net)$101,888$104,911$107,940$110,892
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$10,305$26,097$32,286$27,657
Tax Assets$0$0$0$0
Other NC Assets$10,227$10,227$10,227$10,236
Total NC Assets$122,420$141,235$150,453$148,785
Other Assets$0$0$0$0
Total Assets$343,671$371,632$398,670$440,694
Liabilities
Payables$3,504$4,040$4,190$9,365
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$5$0$212$393
Other Curr. Liab.$2,280$795$0$11,638
Total Curr. Liab.$28,111$28,673$28,159$38,522
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$7,000$5,920$5,317$5,597
Total NC Liab.$81,494$81,595$82,102$83,446
Other Liabilities$0$0$0$0
Cap. Leases$79,245$81,331$83,329$85,265
Total Liabilities$109,605$110,268$110,261$121,968
Equity
Pref Stock$3$3$3$3
Common Stock$115$115$115$114
Retained Earnings-$1,501,935-$1,469,685-$1,435,615-$1,397,994
AOCI$153$62$191$268
Other Equity$0$0$0$0
Total Equity$234,066$261,364$288,409$318,726
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$343,671$371,632$398,670$440,694
Net Debt-$40,622-$41,249-$44,920-$36,056